Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Lybe Scientific AS
AS
Active
Org 926682520
Laboratoriesenteret Erling Skjalgssons Gate 1, 7030
Trondheim
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 5 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Lybe Scientific AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
19M
14M
9M
5M
0M
2021: 15M
15M
2021
2022: 6M (-60% vs 2021)
6M
-60%
2022
2023: 2M (-67% vs 2022)
2M
-67%
2023
2024: 5M (+150% vs 2023)
5M
+150%
2024
EBITDA
NOK millions
5M
3M
0M
-2M
-4M
2021: 3M
3M
2021
2022: -1M (-133% vs 2021)
-1M
-133%
2022
2023: -2M (-100% vs 2022)
-2M
-100%
2023
2024: 2M (+200% vs 2023)
2M
+200%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
Revenue
4 938
2 148
6 229
14 977
Staff expenses
−0
−230
−2 372
−795
EBITDA
1 956
−1 570
−508
3 366
Depreciation & amort.
−1 453
−785
−290
−155
EBIT
502
−2 355
−798
3 211
Net financials
−415
−28
−103
−6
Profit before tax
87
−2 383
−901
3 205
Tax
−0
177
−191
705
Net profit
87
−2 559
−710
2 500
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
Total assets
17 765
12 892
10 915
5 313
Equity
8 842
5 201
1 900
2 610
Long-term debt
3 667
3 550
4 576
714
Short-term debt
5 256
4 141
4 439
1 989
Total debt
8 923
7 691
9 015
2 703
Financial ratios
5-year trend
EBITDA margin
39,6 %
This company
15,8 %
Market median
This company
Market median
151% above market
2021
2024
Equity ratio
49,8 %
This company
38,2 %
Market median
This company
Market median
30% above market
2021
2024
Return on equity
1,0 %
This company
18,4 %
Market median
This company
Market median
95% below market
2021
2024
Net profit margin
1,8 %
This company
8,1 %
Market median
This company
Market median
78% below market
2021
2024
Asset turnover
0,28×
This company
1,12×
Market median
This company
Market median
75% below market
2021
2024
Debt / equity
1,01×
This company
0,62×
Market median
This company
Market median
63% above market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-27 – 2021-12-31
View
PDF
More on Lybe Scientific AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
